[HTML][HTML] Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16− Monocytes From COVID-19 Patients
…, A Rupert, S Namasivayan, J Rocco, F Galindo… - Frontiers in …, 2022 - frontiersin.org
The poor outcome of the coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2, is
associated with systemic hyperinflammatory response and immunopathology. Although …
associated with systemic hyperinflammatory response and immunopathology. Although …
Clinical, virologic, and immunologic evaluation of symptomatic coronavirus disease 2019 rebound following nirmatrelvir/ritonavir treatment
…, KL Boswell, E Laidlaw, F Galindo… - Clinical Infectious …, 2023 - academic.oup.com
Background Nirmatrelvir/ritonavir, the first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
protease inhibitor, reduces the risk of hospitalization and death by …
protease inhibitor, reduces the risk of hospitalization and death by …
[HTML][HTML] Activation of complement components on circulating blood monocytes from COVID-19 patients
…, JM Rocco, E Laidlaw, A Rupert, F Galindo… - Frontiers in …, 2022 - frontiersin.org
The coronavirus disease-2019 (COVID-19) caused by the SARS-CoV-2 virus may vary from
asymptomatic to severe infection with multi-organ failure and death. Increased levels of …
asymptomatic to severe infection with multi-organ failure and death. Increased levels of …
Mycobacterial immune reconstitution inflammatory syndrome in HIV is associated with protein-altering variants in hemophagocytic lymphohistiocytosis-related genes
JM Rocco, E Laidlaw, F Galindo… - The Journal of …, 2023 - academic.oup.com
People with HIV (PWH) and mycobacterial infections can develop immune reconstitution
inflammatory syndrome (IRIS) after starting antiretroviral therapy. The pathophysiology of …
inflammatory syndrome (IRIS) after starting antiretroviral therapy. The pathophysiology of …
Severe mycobacterial immune reconstitution inflammatory syndrome (IRIS) in advanced human immunodeficiency virus (HIV) has features of hemophagocytic …
JM Rocco, E Laidlaw, F Galindo… - Clinical Infectious …, 2023 - academic.oup.com
Background People with HIV and mycobacterial infections can develop immune
reconstitution inflammatory syndrome (IRIS) after starting antiretroviral therapy (ART). Severe …
reconstitution inflammatory syndrome (IRIS) after starting antiretroviral therapy (ART). Severe …
[HTML][HTML] Plasma metabolomics reveals dysregulated metabolic signatures in HIV-associated immune reconstitution inflammatory syndrome
…, A Rupert, EW Dahlstrom, F Galindo… - Frontiers in …, 2021 - frontiersin.org
Immune reconstitution inflammatory syndrome (IRIS) is an inflammatory complication
associated with an underlying opportunistic infection that can be observed in HIV-infected …
associated with an underlying opportunistic infection that can be observed in HIV-infected …
[HTML][HTML] COVID-19 redux: clinical, virologic, and immunologic evaluation of clinical rebound after nirmatrelvir/ritonavir
BP Epling, JM Rocco, KL Boswell, E Laidlaw, F Galindo… - medRxiv, 2022 - ncbi.nlm.nih.gov
Clinical rebound of COVID-19 after nirmatrelvir/ritonavir treatment has been reported. We
performed clinical, virologic, and immune measurements in seven patients with symptomatic …
performed clinical, virologic, and immune measurements in seven patients with symptomatic …
Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients
…, A Bennett, A Lisco, A Kellog, F Galindo… - Frontiers in …, 2024 - frontiersin.org
Introduction COVID-19 patients can develop autoantibodies against a variety of secreted
and membrane proteins, including some expressed on lymphocytes. However, it is unclear …
and membrane proteins, including some expressed on lymphocytes. However, it is unclear …
[HTML][HTML] Clonal hematopoiesis in people with advanced HIV and associated inflammatory syndromes
© 2024 Rocco et al. This work is licensed under the Creative Commons Attribution 4.0
International License. To view a copy of this license, visit http://creativecommons …
International License. To view a copy of this license, visit http://creativecommons …
Long-term Outcomes of Patients With HIV and Pneumocystis jirovecii Pneumonia in the Antiretroviral Therapy Era
…, A Sirajuddin, E Laidlaw, F Galindo… - Open forum …, 2023 - academic.oup.com
Background Pneumocystis jirovecii pneumonia (PCP) is one of the most frequent
opportunistic infections in people with HIV (PWH). However, there are limited data on long-term …
opportunistic infections in people with HIV (PWH). However, there are limited data on long-term …
